Upinder Singh
5 Papers
27 Citations
Upinder Singh is an academic researcher. The author has contributed to research in topics: Medicine & Positron emission tomography. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
Craig Curtis,Jose Gamez,Upinder Singh,Carl H. Sadowsky,Teresa Villena,Marwan N. Sabbagh,Thomas G. Beach,Ranjan Duara,Adam S. Fleisher,Adam S. Fleisher,Kirk A. Frey,Zuzana Walker,Zuzana Walker,Arvinder Hunjan,Clive Holmes,Yavir M. Escovar,Carla X. Vera,Marc Agronin,Joel Ross,Andrea Bozoki,Mary Akinola,Jiong Shi,Rik Vandenberghe,Milos D. Ikonomovic,Paul Sherwin,Igor D. Grachev,Igor D. Grachev,G. Farrar,Adrian Smith,Christopher Buckley,Richard McLain,Stephen Salloway,Stephen Salloway +32 more
TL;DR: This study showed that flutemetamol injection labeled with radioactive fluorine 18 was safe and had high sensitivity and specificity in an end-of-life population and may increase diagnostic accuracy in cognitively impaired patients.
284
The Alzheimer's Questionnaire: A Proof of Concept Study for a New Informant-Based Dementia Assessment
Marwan N. Sabbagh,Michael Malek-Ahmadi,Rahul Kataria,Christine Belden,Donald J. Connor,Caleb Pearson,Sandra Jacobson,Kathryn A. Davis,Roy Yaari,Upinder Singh +9 more
TL;DR: This pilot study indicates that the Alzheimer's Questionnaire is a brief, measure for detecting both MCI and AD and could be easily implemented in a primary care setting.
Validation and diagnostic accuracy of the Alzheimer's questionnaire
Michael Malek-Ahmadi,Kathryn A. Davis,Christine Belden,Brecken Laizure,Sandra Jacobson,Roy Yaari,Upinder Singh,Marwan N. Sabbagh +7 more
TL;DR: The AQ is a valid informant-based instrument for identifying cognitive impairment, which has high sensitivity and specificity in detecting both MCI and AD and allows clinicians to quickly and accurately assess individuals with reported cognitive problems.
Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California
TL;DR: This paper employed a Spanish/English bilingual research coordinator to increase awareness of newly available treatments with FDA Emergency Use Authorization and clinical trial opportunities for Latino outpatients with mild to moderate COVID-19.
1
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
Stephen Salloway,Jose Gamez,Upinder Singh,Carl H. Sadowsky,Teresa Villena,Marwan N. Sabbagh,Thomas G. Beach,Ranjan Duara,Adam S. Fleisher,Kirk A. Frey,Zuzana Walker,Arvinder Hunjan,Yavir M. Escovar,Marc Agronin,Joel Ross,Andrea Bozoki,Mary Akinola,Jiong Shi,Rik Vandenberghe,Milos D. Ikonomovic,Paul Sherwin,Gill Farrar,Adrian Smith,Christopher Buckley,Dietmar Rudolf Thal,Michelle Zanette,Craig Curtis +26 more
TL;DR: Performance of the amyloid tracer [18F]flutemetamol was evaluated against three pathology standard of truth (SoT) measures including neuritic plaques and CERAD “ original” and “modified”.